J Clin Endocrinol Metab 81(1):327332 Zinman B, Hoogwerf BJ, Durn Garca S, Milton DR, Giaconia JM, Kim DD et al (2007) The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial
All cited studies are conducted in rodent or in-vitro systems consistent with RUO classification
About TUL and United Biotechnology Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China
However, there is one important detail: The FDA has not issued a final approval decision
There are people who have BRCA genes, breast cancer genes
Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin